POS0266 CELLULAR IMMUNE RESPONSE PERSISTENCE AFTER COVID-19 MRNA VACCINES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS UNDER RITUXIMAB

  • Marin J.
  • Bourgoin P.
  • Saverna N.
  • Cartagena García C.
  • Lafforgue P.
  • Roudier J.
  • Busnel J.
  • Balandraud N.

ART